Skip to main content

Table 3 Endoscopic manifestations and pathological results for 27 patients

From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

Variable

Patient group (n = 27)

Rate (%)

Tumour site

  

 Gastric fundus and/or body

22

81.5

 Gastric antrum

0

0

 No polyps

5

18.5

Tumour number

  

 Single tumour

4

14.8

 Multiple tumours

18

66.7

 No polyps

5

18.5

Maximum tumour diameter (cm)

  

 < 1

19

70.3

 1–2

3

11.1

 > 2

0

0

 No polyps

5

18.5

Depth of tumour invasion

  

 Mucosal layer

20

74.1

 Submucosal layer

2

7.4

 No polyps

5

18.5

Tumour morphology

  

 Polyp or protuberance

22

81.5

 No polyps

5

18.5

Pathological results

  

 Chronic inflammation

6

22.2

 Hyperplasia

11

40.7

 Dysplasia

2

7.4

 Tumour

8

29.6

OLGIM stage

  

 Stage 0

18

66.7

 Stage I

6

22.2

 Stage II

3

11.1

 Stage III

0

0

 Stage IV

0

0